← back to search

Ritesh R. Kotecha

Spanish Oncology Genitourinary Group · US
Area of research
Pulmonary and Respiratory Medicine · Molecular Biology
Research interest
Research interests include Renal cell carcinoma treatment, Renal and related cancers, Cancer Genomics and Diagnostics, and Cancer Immunotherapy and Biomarkers.
h-index
25
citations
2,896
works
226
NIH funding
—
primary concept
Medicine
email
kotechar@mskcc.org

Recent publications

The SLC1A1/EAAT3 dicarboxylic amino acid transporter is an epigenetically dysregulated nutrient carrier that sustains oncogenic metabolic programs
Nature Communications 2025cited by 2position: middledoi
A Phase 2 Trial of Talazoparib and Avelumab in Genomically Defined Metastatic Kidney Cancer
European Urology Oncology 2023cited by 15position: firstdoi
Phase II Trial of Cabozantinib Plus Nivolumab in Patients With Non–Clear-Cell Renal Cell Carcinoma and Genomic Correlates
Journal of Clinical Oncology 2022cited by 191position: middledoi
PD-1 directed immunotherapy alters Tfh and humoral immune responses to seasonal influenza vaccine
Nature Immunology 2022cited by 78position: middledoi
Deciphering radiological stable disease to immune checkpoint inhibitors
Annals of Oncology 2022cited by 50position: middledoi
Genomic and Metabolic Hallmarks of SDH- and FH-deficient Renal Cell Carcinomas
European Urology Focus 2022cited by 25position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Robert J. Motzer · Texas Oncology3 papers (2022–2023)Mark Zucker · Kettering University3 papers (2022–2023)Maria I. Carlo · Clinica Mediterranea3 papers (2022–2023)Ed Reznik · Motlow State Community College3 papers (2022–2023)Martin H. Voss · Spanish Oncology Genitourinary Group3 papers (2022–2023)Ying‐Bei Chen · Johns Hopkins University3 papers (2022–2023)Chung‐Han Lee · Exelixis (United States)3 papers (2022–2023)Andrea Knežević · University of Zagreb2 papers (2022–2023)Neil J. Shah · Bellevue Hospital Center2 papers (2022–2023)David H. Aggen · New York Oncology Hematology2 papers (2022–2023)Darren R. Feldman · Weill Cornell Medicine2 papers (2022–2023)Deaglan Joseph McHugh · Weill Cornell Medicine2 papers (2022–2023)Matthew D. Hellmann · Weill Cornell Medicine1 papers (2022–2022)Paul Russo · Fondazione Toscana Gabriele Monasterio1 papers (2022–2022)Chloe Dadoun · Memorial Sloan Kettering Cancer Center1 papers (2022–2022)Anthony J. Gill · The University of Sydney1 papers (2022–2022)Nikolaus Schultz · Cancer Clinic1 papers (2022–2022)Natalie Shapnik · Memorial Sloan Kettering Cancer Center1 papers (2022–2022)Renzo G. DiNatale · Franciscan Health1 papers (2022–2022)Andrew J. Plodkowski · Manhattan Scientifics (United States)1 papers (2022–2022)